News

Published on 25 Nov 2021 on Zacks via Yahoo Finance

Lilly (LLY) Up 4.7% Since Last Earnings Report: Can It Continue?


Article preview image

A month has gone by since the last earnings report for Eli Lilly (LLY). Shares have added about 4.7% in that time frame, outperforming the S&P 500.

Will the recent positive trend continue leading up to its next earnings release, or is Lilly due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.

Q3 Earnings Miss, COVID Drugs Drive Sales

NYSE.LLY price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies

Eli Lilly and Company LLY announced that its pipeline candidate, tirzepatide, met all primary and...

Zacks via Yahoo Finance 18 Apr 2024

Company News for Apr 18, 2024

Eli Lilly and Company (LLY) shares rose 0.5% after announcing positive late-stage results for its...

Zacks via Yahoo Finance 18 Apr 2024

14 Best Large Cap Dividend Growth Stocks To Buy Now

In this article, we discuss 14 best large-cap dividend growth stocks to buy now. You can skip our...

Insider Monkey via Yahoo Finance 18 Apr 2024

Eli Lilly's Mounjaro, Zepbound to remain in shortage through end of Q2 (NYSE:LLY)

Eli Lilly's semaglutide-based drugs for diabetes and weight loss, Mounjaro and Zepbound, will fac...

Seeking Alpha 17 Apr 2024

Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says

Zepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea,...

CNN.com 17 Apr 2024

The Week in Pictures: April 5 - April 12

From the ongoing conflict between Israel and Hamas, to UEFA Champions League quarter finals, to t...

dpa international via Yahoo News 12 Apr 2024

GLP-1s benefit Parkinson’s: Barclays sees biopharma impact

Barclays cites implications for the biopharma sector after a mid-stage trial showed that the GLP-...

Seeking Alpha 12 Apr 2024

Trillion-Dollar Trajectories: 3 Billion-Dollar Stocks With the Potential to Hit the Next Milestone

Reaching the trillion-dollar market cap is a testament to any company’s international influence,...

InvestorPlace 11 Apr 2024

Jim Cramer Stands By Nvidia And Eli Lilly Despite Market Dips, Says 'Terrific Time To Take Some...

Jim Cramer, CNBC’s market commentator, recently shared his insights on Tuesday’s market activity....

Benzinga 9 Apr 2024

Eli Lilly eyes $2.5B plant to make obesity drugs (NYSE:LLY)

Eli Lilly (LLY) begins construction of a $2.5B manufacturing plant in Germany to meet demand for ...

Seeking Alpha 9 Apr 2024